Sex differences in response to opioid drugs

November 9, 2007

It appears that women respond better to morphine than men and men respond better to a different opioid (narcotic) drug, butorphanol. This was the conculsion of a study presented at the American Pain Society. The next step that the researchers plan is to look at possible genetic factors which may explain this difference. Although the study was small and needs to be confirmed, such knowledge could have an important practical impact. Opioid drugs are rarely used for the treatment of headaches, but when necessary it would be useful to know which one has a better chance of success.

Written by
Alexander Mauskop, MD
Continue reading
August 8, 2026
Sugar is bad for your brain, even before you are born.
Sugar consumed in the first two years of life increases the risk of dementia.
Read article
August 6, 2026
Research
An Old Medicine that Could Make Brain Stimulation Work Better for Depression and Other Neurological Conditions
A 2022 clinical trial from the University of Calgary found that adding low‑dose D‑cycloserine (DCS), a partial NMDA‑receptor agonist, to intermittent theta‑burst stimulation (iTBS) significantly increased response and remission rates in depression without serious side effects. Early follow‑up data suggest that timing, dose, and drug levels matter, and raise the possibility that this DCS‑TMS approach could eventually be applied to other neurological conditions—such as migraine, postconcussion syndrome, brain fog, and long COVID
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe